Literature DB >> 29502347

Acupuncture for depression.

Caroline A Smith1, Mike Armour, Myeong Soo Lee, Li-Qiong Wang, Phillipa J Hay.   

Abstract

BACKGROUND: Depression is recognised as a major public health problem that has a substantial impact on individuals and on society. People with depression may consider using complementary therapies such as acupuncture, and an increasing body of research has been undertaken to assess the effectiveness of acupuncture for treatment of individuals with depression. This is the second update of this review.
OBJECTIVES: To examine the effectiveness and adverse effects of acupuncture for treatment of individuals with depression.To determine:• Whether acupuncture is more effective than treatment as usual/no treatment/wait list control for treating and improving quality of life for individuals with depression.• Whether acupuncture is more effective than control acupuncture for treating and improving quality of life for individuals with depression.• Whether acupuncture is more effective than pharmacological therapies for treating and improving quality of life for individuals with depression.• Whether acupuncture plus pharmacological therapy is more effective than pharmacological therapy alone for treating and improving quality of life for individuals with depression.• Whether acupuncture is more effective than psychological therapies for treating and improving quality of life for individuals with depression.• Adverse effects of acupuncture compared with treatment as usual/no treatment/wait list control, control acupuncture, pharmacological therapies, and psychological therapies for treatment of individuals with depression. SEARCH
METHODS: We searched the following databases to June 2016: Cochrane Common Mental Disorders Group Controlled Trials Register (CCMD-CTR), Korean Studies Information Service System (KISS), DBPIA (Korean article database website), Korea Institute of Science and Technology Information, Research Information Service System (RISS), Korea Med, Korean Medical Database (KM base), and Oriental Medicine Advanced Searching Integrated System (OASIS), as well as several Korean medical journals. SELECTION CRITERIA: Review criteria called for inclusion of all published and unpublished randomised controlled trials comparing acupuncture versus control acupuncture, no treatment, medication, other structured psychotherapies (cognitive-behavioural therapy, psychotherapy, or counselling), or standard care. Modes of treatment included acupuncture, electro-acupuncture, and laser acupuncture. Participants included adult men and women with depression diagnosed by Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV), Research Diagnostic Criteria (RDC), International Statistical Classification of Diseases and Related Health Problems (ICD), or Chinese Classification of Mental Disorders Third Edition Revised (CCMD-3-R). If necessary, we used trial authors' definitions of depressive disorder. DATA COLLECTION AND ANALYSIS: We performed meta-analyses using risk ratios (RRs) for dichotomous outcomes and standardised mean differences (SMDs) for continuous outcomes, with 95% confidence intervals (CIs). Primary outcomes were reduction in the severity of depression, measured by self-rating scales or by clinician-rated scales, and improvement in depression, defined as remission versus no remission. We assessed evidence quality using the GRADE method. MAIN
RESULTS: This review is an update of previous versions and includes 64 studies (7104 participants). Most studies were at high risk of performance bias, at high or unclear risk of detection bias, and at low or unclear risk of selection bias, attrition bias, reporting bias, and other bias.Acupuncture versus no treatment/wait list/treatment as usualWe found low-quality evidence suggesting that acupuncture (manual and electro-) may moderately reduce the severity of depression by end of treatment (SMD -0.66, 95% CI -1.06 to -0.25, five trials, 488 participants). It is unclear whether data show differences between groups in the risk of adverse events (RR 0.89, 95% CI 0.35 to 2.24, one trial, 302 participants; low-quality evidence).Acupuncture versus control acupuncture (invasive, non-invasive sham controls)Acupuncture may be associated with a small reduction in the severity of depression of 1.69 points on the Hamilton Depression Rating Scale (HAMD) by end of treatment (95% CI -3.33 to -0.05, 14 trials, 841 participants; low-quality evidence). It is unclear whether data show differences between groups in the risk of adverse events (RR 1.63, 95% CI 0.93 to 2.86, five trials, 300 participants; moderate-quality evidence).Acupuncture versus medicationWe found very low-quality evidence suggesting that acupuncture may confer small benefit in reducing the severity of depression by end of treatment (SMD -0.23, 95% CI -0.40 to -0.05, 31 trials, 3127 participants). Studies show substantial variation resulting from use of different classes of medications and different modes of acupuncture stimulation. Very low-quality evidence suggests lower ratings of adverse events following acupuncture compared with medication alone, as measured by the Montgomery-Asberg Depression Rating Scale (MADRS) (mean difference (MD) -4.32, 95% CI -7.41 to -1.23, three trials, 481 participants).Acupuncture plus medication versus medication aloneWe found very low-quality evidence suggesting that acupuncture is highly beneficial in reducing the severity of depression by end of treatment (SMD -1.15, 95% CI -1.63 to -0.66, 11 trials, 775 participants). Studies show substantial variation resulting from use of different modes of acupuncture stimulation. It is unclear whether differences in adverse events are associated with different modes of acupuncture (SMD -1.32, 95% CI -2.86 to 0.23, three trials, 200 participants; very low-quality evidence).Acupuncture versus psychological therapyIt is unclear whether data show differences between acupuncture and psychological therapy in the severity of depression by end of treatment (SMD -0.5, 95% CI -1.33 to 0.33, two trials, 497 participants; low-quality evidence). Low-quality evidence suggests no differences between groups in rates of adverse events (RR 0.62, 95% CI 0.29 to 1.33, one trial, 452 participants). AUTHORS'
CONCLUSIONS: The reduction in severity of depression was less when acupuncture was compared with control acupuncture than when acupuncture was compared with no treatment control, although in both cases, results were rated as providing low-quality evidence. The reduction in severity of depression with acupuncture given alone or in conjunction with medication versus medication alone is uncertain owing to the very low quality of evidence. The effect of acupuncture compared with psychological therapy is unclear. The risk of adverse events with acupuncture is also unclear, as most trials did not report adverse events adequately. Few studies included follow-up periods or assessed important outcomes such as quality of life. High-quality randomised controlled trials are urgently needed to examine the clinical efficacy and acceptability of acupuncture, as well as its effectiveness, compared with acupuncture controls, medication, or psychological therapies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29502347      PMCID: PMC6494180          DOI: 10.1002/14651858.CD004046.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  132 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

Review 2.  The nuts and bolts of low-level laser (light) therapy.

Authors:  Hoon Chung; Tianhong Dai; Sulbha K Sharma; Ying-Ying Huang; James D Carroll; Michael R Hamblin
Journal:  Ann Biomed Eng       Date:  2011-11-02       Impact factor: 3.934

Review 3.  A cumulative review of the range and incidence of significant adverse events associated with acupuncture.

Authors:  Adrian White
Journal:  Acupunct Med       Date:  2004-09       Impact factor: 2.267

4.  Introducing a placebo needle into acupuncture research.

Authors:  K Streitberger; J Kleinhenz
Journal:  Lancet       Date:  1998-08-01       Impact factor: 79.321

5.  [Acupuncture for post-stroke depression: a randomized controlled trial].

Authors:  Hong-Jie Li; Bao-Liang Zhong; Yin-Ping Fan; Hong-Tao Hu
Journal:  Zhongguo Zhen Jiu       Date:  2011-01

Review 6.  Acupuncture for depression.

Authors:  C A Smith; P P J Hay
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

7.  [Clinical observation on depression treated by electroacupuncture combined with western medicine].

Authors:  Lei Xu; Ling-Ling Wang
Journal:  Zhongguo Zhen Jiu       Date:  2011-09

8.  Clinical research of acupuncture on malignant tumor patients for improving depression and sleep quality.

Authors:  Yu Feng; Xin-Yu Wang; Shao-Dan Li; Yin Zhang; Hai-Ming Wang; Min Li; Ke Cao; Yu-Fei Ye; Zhao Zhang
Journal:  J Tradit Chin Med       Date:  2011-09       Impact factor: 0.848

9.  Cost of depression among adults in England in 2000.

Authors:  Christine M Thomas; Stephen Morris
Journal:  Br J Psychiatry       Date:  2003-12       Impact factor: 9.319

10.  [Acupuncture for treatment of depressive neurosis: a multi-center randomized controlled study].

Authors:  Wen-bin Fu; Li Fan; Xao-ping Zhu; Qing He; Ling Wang; Li-xing Zhuang; Yan-sheng Liu; Chun-zhi Tang; Ying-wen Li; Chang-rong Meng; Hong-lai Zhang; Jie Yan
Journal:  Zhongguo Zhen Jiu       Date:  2008-01
View more
  37 in total

1.  Overcoming Barriers in Clinical Acupuncture Research: Translating Clinical Practice into Fundamental Science.

Authors:  Rosa N Schnyer; Lee Hullender Rubin
Journal:  Med Acupunct       Date:  2020-12-16

2.  Antidepressant Monotherapy and Combination Therapy with Acupuncture in Depressed Patients: A Resting-State Functional Near-Infrared Spectroscopy (fNIRS) Study.

Authors:  Yat Kwan Wong; Jun Mei Wu; Guodong Zhou; Frank Zhu; Quan Zhang; Xin Jing Yang; Zongshi Qin; Ni Zhao; Haiyong Chen; Zhang-Jin Zhang
Journal:  Neurotherapeutics       Date:  2021-08-24       Impact factor: 6.088

3.  Discussion on Collection of Clinical Questions in International Clinical Practice Guidelines of Acupuncture-Moxibustion.

Authors:  Xiao-Dong Wu; Nan-Qi Zhao; Nan Ding; Jing-Yun Yuan; Guo-Feng Dong; Xin Wang; Bao-Yan Liu
Journal:  Chin J Integr Med       Date:  2022-08-31       Impact factor: 2.626

4.  The Efficacy and Safety of Acupuncture for Depression-Related Insomnia: Protocol for a Systematic Review and Meta-Analysis.

Authors:  Hantong Hu; Zengtu Li; Yingying Cheng; Hong Gao
Journal:  J Pain Res       Date:  2022-07-13       Impact factor: 2.832

5.  Acupuncture Ameliorates Depressive Behaviors by Modulating the Expression of Hippocampal Iba-1 and HMGB1 in Rats Exposed to Chronic Restraint Stress.

Authors:  Lu Chen; Huili Jiang; Tuya Bao; Yu Wang; Hong Meng; Yang Sun; Pengfei Liu; Songxiao Quan; Wenshan Li; Simin Qi; Xiujun Ren
Journal:  Front Psychiatry       Date:  2022-06-06       Impact factor: 5.435

6.  Do Palliative Care Providers Use Complementary and Integrative Medicine? A Nationwide Survey.

Authors:  Anurag Ratan Goel; Charles R Henderson; Manney Carrington Reid
Journal:  J Pain Symptom Manage       Date:  2021-11-14       Impact factor: 5.576

Review 7.  [Acupuncture for treatment of depressive disorders in pain diseases].

Authors:  K Sallach; M Leonhardt
Journal:  Nervenarzt       Date:  2018-09       Impact factor: 1.214

Review 8.  Characteristics of Provider-Focused Research on Complementary and Integrative Medicine in Palliative Care: A Scoping Review.

Authors:  Anurag Ratan Goel; Hana Elhassan; Melissa Patterson; M Carrington Reid
Journal:  Am J Hosp Palliat Care       Date:  2021-04-23       Impact factor: 2.090

9.  Reserpine-induced altered neuro-behavioral, biochemical and histopathological assessments prevent by enhanced antioxidant defence system of thymoquinone in mice.

Authors:  Noreen Samad; Natasha Manzoor; Zahra Muneer; Sheraz A Bhatti; Imran Imran
Journal:  Metab Brain Dis       Date:  2021-07-26       Impact factor: 3.584

10.  Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial.

Authors:  Mikyung Kim; Eun-Ji Choi; O-Jin Kwon; Hyo-Ju Park; Ae-Ran Kim; Bok-Nam Seo; Sun-Yong Chung; Jun-Hwan Lee; Joo-Hee Kim
Journal:  Integr Med Res       Date:  2021-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.